The Optimal Transfusion Strategy in Liver Transplantation: The Quest Continues
Journal Title: Annals of Hepatology - Year 2017, Vol 16, Issue 6
Abstract
-
Authors and Affiliations
Nicolas M. Intagliata, Patrick G. Northup, Stephen H. Caldwell
Keywords
Related Articles
- EP ID EP228007
- DOI 10.5604/01.3001.0010.5270
- Views 103
- Downloads 0
Good outcomes of liver transplantation for hepatitis C at a low volume centre
Background and aims. Concerns exist about outcomes of liver transplantation (LT) from low volume centres, especially for hepatitis C (HCV) patients. The aim of the study was to assess patient outcomes as well as their pr...
Noninvasive markers of fibrosis: key concepts for improving accuracy in daily clinical practice
Noninvasive markers of fibrosis have emerged as an alternative to the staging of fibrosis by means of liver biopsy. Apart from being noninvasive and thus lacking the adverse effects of liver biopsy, they offer some adva...
Clinical approach to the patient with chronic hepatitis C infection and normal aminotransferases
Approximately 30% of patients with chronic HCV infection have persistently normal alanine aminotransferase levels (PNALT). Most of these patients have minimal or mild inflammation and absent or minimal fibrosis, although...
Analysis of the MELD Score Impact in the Outcome of Endovascular Portal Vein Reconstruction
Introduction. Endovascular therapy represents a less invasive alternative to open surgery for reconstruction of the portal vein (PV) and the spleno-mesenteric venous confluence to treat Portal hypertension. The objective...
Hepatoprotective Effect of Curcumin on Hepatocellular Carcinoma Through Autophagic and Apoptic Pathways
Background and rationale. Microtubule-associated protein light chain 3-II (LC3-II), and Sequestosome-1 (SQSTM1) are proteins that can be used as markers for autophagic pathway. Bcl-2 protein is reported to be inversely c...